Billionaires are investing heavily in a cutting-edge tech company specializing in the creation of genetically engineered monkey organs, with hopes that lab-grown human parts could soon follow.
Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” grown from human cells. R3 Bio, a billionaire-backed biotech startup, is ...
Scientists in Tokyo have developed a groundbreaking, label-free method to identify aging human cells using electric fields. This new technique avoids the downsides of chemical tagging, which can ...
Using mathematical analysis of patterns of human and animal cell behavior, scientists say they have developed a computer program that mimics the behavior of such cells in any part of the body. Led by ...
Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to aid in colorectal cancer research and drug discovery. The "3D in vivo ...
The field of infectious disease research faces persistent challenges in bridging the gap between laboratory findings and successful clinical translation.
Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” grown from human cells. R3 Bio, a billionaire-backed biotech startup, is ...